NXTC - NextCure, Inc. Debt to Book Capitalization Ratio

The ratio of debt obligations to balance sheet equity demonstrates the credit load of NextCure, Inc. (NXTC), where the value 0.35 shows the current magnitude. The automation of tissue analysis via robotics accelerates scientific research, reducing personnel risks. NextCure, Inc. (NXTC) creates unique antibodies through the FIND platform to combat cancer, strictly adhering to environmental regulations for biohazardous waste disposal.

NXTC NextCure, Inc.: Debt to Book Capitalization Ratio in the range 07/04/2022 - 10/27/2026

Summary analytical data breakdowns for NextCure Inc (NXTC)

- price and consensus price forecast:

Stock Price NextCure, Inc.|NXTC - Consensus Target

- market capitalization data:

Market Value NextCure Corporation|NXTC - Total Enterprise Value

- book capitalization data:

Net Assets per Single Share NextCure|NXTC - Company Book Value|Market Value to Book Value Ratio nextcure.com|NXTC - Company Assets

- debt and liquidity data:

Total Debt to Capital NextCure, Inc.|NXTC - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio NextCure Corp|NXTC - Company Cumulative Debt|Debt to Book Value NextCure Corporation

Analysis of all company metrics:NXTC, NextCure, Inc.

Finished products of NextCure Corporation

This ratio measures the proportion of debt relative to the company's equity on the balance sheet. Low values indicate financial stability, while an increase points to a rising debt load. By analyzing the debt-to-book capitalization trend, an investor assesses the risk of bankruptcy. For NextCure, Inc. (NXTC), this is critical, as R&D processes depend on liquidity. Stable leverage confirms the ability of patents to sustain the business until clinical trials are completed.

Competitors of NextCure, Inc.